Carl Hansen ^Leaders

Carl Hansen, as CEO of AbCellera Biologics Inc., leads the firm in its quest to advance human antibody research. Based in Vancouver, the company stands out by its unique Pandemic Prevention Platform, an initiative of DARPA. Its unique Trianni humanized mouse platform, a result of in-house in silico antibody gene design, provides a vast array of antibody diversities, a testament to Hansen's visionary leadership.